Latest On Bio-Techne Corporation (TECH):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-08-19 05:54 EST | Dividend | A dividend of $0.08 has been announced on Aug 7, 2024. It will be paid Aug 30, 2024 with an ex-dividend date of Aug 19, 2024. | Neutral |  |
| 2024-05-10 05:54 EST | Dividend | A dividend of $0.08 has been announced on May 1, 2024. It will be paid May 24, 2024 with an ex-dividend date of May 10, 2024. | Neutral | |
| 2024-02-09 04:54 EST | Dividend | A dividend of $0.08 has been announced on Feb 1, 2024. It will be paid Feb 26, 2024 with an ex-dividend date of Feb 9, 2024. | Neutral | |
| 2023-11-09 04:54 EST | Dividend | A dividend of $0.08 has been announced on Oct 31, 2023. It will be paid Nov 24, 2023 with an ex-dividend date of Nov 9, 2023. | Neutral | |
| 2023-08-17 05:53 EST | Dividend | A dividend of $0.08 has been announced on Aug 8, 2023. It will be paid Sep 1, 2023 with an ex-dividend date of Aug 17, 2023. | Neutral | |
| 2023-05-19 01:49 EST | News | Bio-Techne Corporation: Long-Term Quality, But At A Price | N/A | |
| 2023-05-12 05:54 EST | Dividend | A dividend of $0.08 has been announced on May 3, 2023. It will be paid May 26, 2023 with an ex-dividend date of May 12, 2023. | Neutral | |
| 2023-05-03 16:01 EST | News | Bio-Techne Non-GAAP EPS of $0.53 in-line, revenue of $294.1M misses by $4.45M | N/A | |
| 2023-05-03 16:00 EST | News | Bio-Techne Corporation (TECH) Q3 2023 Earnings Call Transcript | N/A | |
| 2023-05-02 14:56 EST | News | Bio-Techne Q3 2023 Earnings Preview | N/A | |
| 2023-02-10 04:53 EST | Dividend | A dividend of $0.08 has been announced on Feb 2, 2023. It will be paid Feb 27, 2023 with an ex-dividend date of Feb 10, 2023. | Neutral | |
| 2023-02-03 00:10 EST | News | Bio-Techne Corporation (TECH) Q2 2023 Earnings Call Transcript | N/A | |
| 2023-02-02 10:00 EST | News | Bio-Techne Non-GAAP EPS of $0.47 misses by $0.02, revenue of $271.58M misses by $18.15M | N/A | |
| 2023-02-02 10:00 EST | News | Bio-Techne declares $0.08 dividend | N/A | |
| 2023-01-27 13:47 EST | News | Bio-Techne: Paring Rating Back To Neutral Until Growth Drivers Stack Up | N/A | |
| 2023-01-10 14:38 EST | News | Agilent, Bio-Techne upgraded as Wells Fargo revises life sciences outlook | N/A | |
| 2022-11-15 08:34 EST | News | Bio-Techne opens new immunoassay manufacturing facility | N/A | |
| 2022-11-11 17:52 EST | News | Bio-Techne: Recent Weakness, Charts Suggest It's Now A Buy (Technical Analysis) | N/A | |
| 2022-11-10 04:54 EST | Dividend | A dividend of $0.32 has been announced on Nov 1, 2022. It will be paid Nov 28, 2022 with an ex-dividend date of Nov 10, 2022. | Neutral | |
| 2022-11-01 16:14 EST | News | Bio-Techne declares $0.32 dividend; announces 4-for-1 split in form of stock dividend | N/A | |
| 2022-11-01 16:14 EST | News | Bio-Techne Non-GAAP EPS of $1.78 misses by $0.05, revenue of $269.65M misses by $12.08M | N/A | |
| 2022-11-01 16:13 EST | News | Bio-Techne (TECH) Q1 2023 Earnings Call Transcript | N/A | |
| 2022-10-11 21:07 EST | News | Bio-Techne releases new AVV viral titer assays | N/A | |
| 2022-09-01 12:12 EST | News | Bio-Techne to seek shareholder approval for 4- for-1 stock split | N/A | |
| 2022-08-19 02:11 EST | News | Bio-Techne releases Quantist Luminex data analysis software | N/A | |
| 2022-08-12 05:54 EST | Dividend | A dividend of $0.32 has been announced on Aug 4, 2022. It will be paid Aug 29, 2022 with an ex-dividend date of Aug 12, 2022. | Neutral | |
| 2022-08-07 11:55 EST | News | Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q4 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-04 17:36 EST | News | Bio-Techne Non-GAAP EPS of $2.05 misses by $0.03, revenue of $288.2M beats by $1.16M | N/A | |
| 2022-08-04 17:36 EST | News | Bio-Teche announces transition plan for CEO Kummeth | N/A | |
| 2022-08-04 02:31 EST | News | Bio-Techne Q4 2022 Earnings Preview | N/A | |
| 2022-07-29 19:06 EST | News | Bio-Techne: Resiliency Comes At A Large Premium | N/A | |
| 2022-07-06 11:30 EST | News | Bio-Techne launches HPV detection test RNAscope in Europe for use in throat cancer | N/A | |
| 2022-06-22 08:32 EST | News | Bio-Techne to acquire single-cell sorting platform provider Namocell | N/A | |
| 2022-05-13 05:54 EST | Dividend | A dividend of $0.32 has been announced on Nov 30, -0001. It will be paid May 27, 2022 with an ex-dividend date of May 13, 2022. | Neutral | |
| 2022-05-04 13:07 EST | News | Bio-Techne Non-GAAP EPS of $2.14 beats by $0.14, revenue of $290.4M beats by $11.13M | N/A | |
| 2022-05-04 13:06 EST | News | Bio-Techne Corporation (TECH) CEO Chuck Kummeth On Q3 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-03 21:16 EST | News | Bio-Techne Q3 2022 Earnings Preview | N/A | |
| 2022-03-23 14:45 EST | News | Bio-Techne - Exceptional Leverage To Biopharma Growth, And Priced Accordingly | N/A | |
| 2022-02-22 11:21 EST | News | Bio-Techne, Thermo Fisher ink contract to develop/sell kidney transplant rejection test | N/A | |
| 2022-02-10 04:54 EST | Dividend | A dividend of $0.32 has been announced on Feb 1, 2022. It will be paid Feb 25, 2022 with an ex-dividend date of Feb 10, 2022. | Neutral | |
| 2022-02-01 16:46 EST | News | Bio-Techne Non-GAAP EPS of $1.88 beats by $0.09, revenue of $269.28M beats by $2.71M | N/A | |
| 2022-02-01 16:46 EST | News | Bio-Techne declares $0.32 dividend and repurchase of $400M of common stock | N/A | |
| 2022-02-01 16:45 EST | News | Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-01-31 23:29 EST | News | Bio-Techne FQ2 2022 Earnings Preview | N/A | |
| 2022-01-05 11:13 EST | News | Akoya Biosciences, Bio-Techne team up to develop spatial multiomics workflow | N/A | |
| 2021-12-14 22:44 EST | News | Bio-Techne enters option agreement with Wilson Wolf | N/A | |
| 2021-12-03 21:34 EST | News | Bio-Techne Is Overpriced - Here's Why | N/A | |
| 2021-11-10 04:55 EST | Dividend | A dividend of $0.32 has been announced on Nov 2, 2021. It will be paid Nov 26, 2021 with an ex-dividend date of Nov 10, 2021. | Neutral | |
| 2021-11-03 00:17 EST | News | Bio-Techne EPS beats by $0.11, beats on revenue | N/A | |
| 2021-11-03 00:16 EST | News | Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q1 2022 Results - Earnings Call Transcript | N/A | |
About Bio-Techne Corporation (TECH):
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates in two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment offers proteins and reagent solutions, including cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and T-Cell activation technologies. This segment also provides manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including Food and Drug Administration -regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for original equipment manufacturers and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays comprising the ExoDx Prostate test for prostate cancer diagnosis. This segment also manufactures and sells tissue-based in-situ hybridization assays for research and clinical use. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
General
- Name Bio-Techne Corporation
- Symbol TECH
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 2,300
- Last Split Factor2:1
- Last Split Date2000-12-04
- Fiscal Year EndJune
- IPO Date1989-02-09
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryLife Sciences Tools & Services
- Gic SubIndustryLife Sciences Tools & Services
- Web URLhttp://www.bio-techne.com
View More
Valuation
- Trailing PE 84.84
- Forward PE 55.87
- Price/Sales (Trailing 12 Mt.) 19.01
- Price/Book (Most Recent Quarter) 9.73
- Enterprise Value Revenue 18.57
- Enterprise Value EBITDA 48.61
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $6.10
- Next Year EPS Estimate $7.12
- Next Quarter EPS Estimate $1.47
- Profit Margin 22%
- Operating Margin 23%
- Return on Assets 6%
- Return on Equity 12%
- Revenue 798.97 million
- Earnings Per Share $4.40
- Revenue Per Share $20.78
- Gross Profit 483.19 million
- Quarterly Earnings Growth 21.3%
View More
Highlights
- Market Capitalization 14.47 billion
- EBITDA 234.26 million
- PE Ratio 69.82
- PEG Ratio 3.09
- Analyst Target Price $417.22
- Book Value Per Share $39.26
View More
Share Statistics
- Shares Outstanding 38.8 million
- Shares Float 38.57 million
- % Held by Insiders 59%
- % Held by Institutions 95.81%
- Shares Short 278617
- Shares Short Prior Month 339766
- Short Ratio 1.31
- Short % of Float 1%
- Short % of Shares Outstanding 1%
View More
Technicals
- Beta 1.11
- 52 Week High $414.99
- 52 Week Low $154.5
- 50 Day Moving Average 373.31
- 200 Day Moving Average 309.85
View More
Dividends
- Forward Annual Dividend Rate $1.28
- Forward Annual Dividend Yield 0.34%
- Payout Ratio 24%
- Dividend Date 2021-02-26
- ExDividend Date 2021-02-11
- Dividend Per Share $1.28
- Dividend Yield 0.43%
View More
Bio-Techne Corporation (TECH) Dividend Calendar:
Bio-Techne Corporation pays an annual dividend of $1.28 per share, with a dividend yield of 0.43%.
TECH's last dividend payment was made to shareholders on February 26, 2021.
Bio-Techne Corporation pays out 24% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Bio-Techne Corporation (TECH) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-02 | $224.25 million | $1.62 | $1.37 | 18.16% |
| 2020-09-30 | 2020-11-05 | $204.2 million | $1.43 | $1.10 | 29.61% |
| 2020-06-30 | 2020-08-04 | $175.83 million | $1.00 | $0.76 | 30.99% |
| 2020-03-31 | 2020-04-30 | $N/A | $1.39 | $1.13 | 22.67% |
| 2019-12-31 | 2020-02-04 | $184.93 million | $1.08 | $1.14 | -4.98% |
| 2019-09-30 | 2019-10-29 | $183.24 million | $1.06 | $1.06 | 0.19% |
| 2019-06-30 | 2019-08-06 | $191.66 million | $1.25 | $1.34 | -6.54% |
| 2019-03-31 | 2019-04-30 | $184.86 million | $1.21 | $1.17 | 3.33% |
| 2018-12-31 | 2019-02-05 | $174.51 million | $1.06 | $1.01 | 4.75% |
| 2018-09-30 | 2018-10-30 | $162.97 million | $0.98 | $0.97 | 0.55% |
| 2018-06-30 | 2018-08-07 | $180.25 million | $1.34 | $1.29 | 3.86% |
| 2018-03-31 | 2018-05-02 | $163.97 million | $1.21 | $1.14 | 6.12% |
| 2017-12-31 | 2018-02-06 | $154.15 million | $1.02 | $0.92 | 11.03% |
| 2017-09-30 | 2017-10-31 | $144.61 million | $0.90 | $0.88 | 2.12% |
| 2017-06-30 | 2017-08-08 | $156.58 million | $1.09 | $0.99 | 10.01% |
| 2017-03-31 | 2017-05-02 | $144.04 million | $0.97 | $0.93 | 4.86% |
| 2016-12-31 | 2017-02-07 | $131.81 million | $0.81 | $0.84 | -3.71% |
| 2016-09-30 | 2016-10-31 | $130.58 million | $0.84 | $0.79 | 6.06% |
| 2016-06-30 | 2016-08-17 | $134.76 million | $0.92 | $0.94 | -2.34% |
| 2016-03-31 | 2016-05-03 | $130.97 million | $1.01 | $0.89 | 13.06% |
| 2015-12-31 | 2016-02-02 | $120.91 million | $0.88 | $0.82 | 7.1% |
| 2015-09-30 | 2015-10-28 | $112.38 million | $0.79 | $0.85 | -7.06% |
| 2015-06-30 | 2015-08-06 | $117.66 million | $0.87 | $0.86 | 1.16% |
| 2015-03-31 | 2015-05-05 | $114.16 million | $0.86 | $0.90 | -4.44% |
| 2014-12-31 | 2015-02-03 | $111.95 million | $0.82 | $0.86 | -4.65% |
| 2014-09-30 | 2014-10-28 | $108.48 million | $0.85 | $0.87 | -2.3% |
| 2014-06-30 | 2014-08-11 | $92.52 million | $0.88 | $0.85 | 3.53% |
| 2014-03-31 | 2014-04-28 | $95.56 million | $0.94 | $0.89 | 5.62% |
| 2013-12-31 | 2014-02-04 | $84.02 million | $0.75 | $0.80 | -6.25% |
| 2013-09-30 | 2013-10-29 | $85.67 million | $0.83 | $0.80 | 3.75% |
| 2013-06-30 | 2013-08-06 | $79.48 million | $0.82 | $0.83 | -1.2% |
| 2013-03-31 | 2013-04-30 | $80.99 million | $0.88 | $0.90 | -2.22% |
| 2012-12-31 | 2013-02-05 | $75.08 million | $0.74 | $0.77 | -3.9% |
| 2012-09-30 | 2012-10-23 | $75.03 million | $0.75 | $0.80 | -6.25% |
| 2012-06-30 | 2012-07-31 | $78.68 million | $0.80 | $0.85 | -5.88% |
| 2012-03-31 | 2012-05-01 | $83.62 million | $0.90 | $0.89 | 1.12% |
| 2011-12-31 | 2012-01-31 | $74.66 million | $0.76 | $0.79 | -3.8% |
| 2011-09-30 | 2011-10-25 | $77.6 million | $0.81 | $0.84 | -3.57% |
| 2011-06-30 | 2011-08-02 | $78.04 million | $0.85 | $0.77 | 10.39% |
| 2011-03-31 | 2011-05-03 | $76.27 million | $0.84 | $0.80 | 5% |
| 2010-12-31 | 2011-02-01 | $67.71 million | $0.69 | $0.68 | 1.47% |
| 2010-09-30 | 2010-10-26 | $67.95 million | $0.71 | $0.73 | -2.74% |
| 2010-06-30 | 2010-08-03 | $66.71 million | $0.69 | $0.71 | -2.82% |
| 2010-03-31 | 2010-05-04 | $70.28 million | $0.75 | $0.79 | -5.06% |
| 2009-12-31 | 2010-02-02 | $65.52 million | $0.66 | $0.68 | -2.94% |
| 2009-09-30 | 2009-10-28 | $66.53 million | $0.72 | $0.70 | 2.86% |
| 2009-06-30 | 2009-08-04 | $64.89 million | $0.68 | $0.69 | -1.45% |
| 2009-03-31 | 2009-04-28 | $67.87 million | $0.74 | $0.72 | 2.78% |
| 2008-12-31 | 2009-02-03 | $61.88 million | $0.62 | $0.64 | -3.13% |
| 2008-09-30 | 2008-10-22 | $69.32 million | $0.74 | $0.66 | 12.12% |
| 2008-06-30 | 2008-08-05 | $67.77 million | $0.70 | $0.67 | 4.48% |
| 2008-03-31 | 2008-04-29 | $69.52 million | $0.76 | $0.66 | 15.15% |
| 2007-12-31 | 2008-01-29 | $62.14 million | $0.60 | $0.54 | 11.11% |
| 2007-09-30 | 2007-10-24 | $57.99 million | $0.58 | $0.57 | 1.75% |
| 2007-06-30 | 2007-08-07 | $58.43 million | $0.58 | $0.57 | 1.75% |
| 2007-03-31 | 2007-05-01 | $60.2 million | $0.60 | $0.60 | 0% |
| 2006-12-31 | 2007-01-30 | $52.51 million | $0.47 | $0.48 | -2.08% |
| 2006-09-30 | 2006-10-25 | $52.35 million | $0.50 | $0.49 | 2.04% |
| 2006-06-30 | 2006-08-08 | $52.07 million | $0.49 | $0.50 | -2% |
| 2006-03-31 | 2006-04-25 | $54.81 million | $0.52 | $0.50 | 4% |
| 2005-12-31 | 2006-01-31 | $48.03 million | $0.42 | $0.41 | 2.44% |
| 2005-09-30 | 2005-10-27 | $47.71 million | $0.43 | $0.42 | 2.38% |
| 2005-06-30 | 2005-08-16 | $47.55 million | $0.47 | $0.43 | 9.3% |
| 2005-03-31 | 2005-04-26 | $47.94 million | $0.45 | $0.42 | 7.14% |
| 2004-12-31 | 2005-02-01 | $42.25 million | $0.36 | $0.35 | 2.86% |
| 2004-09-30 | 2004-10-21 | $40.92 million | $0.34 | $0.35 | -2.86% |
| 2004-06-30 | 2004-08-10 | $42.46 million | $0.32 | $0.35 | -8.57% |
| 2004-03-31 | 2004-04-27 | $42.54 million | $0.35 | $0.33 | 6.06% |
| 2003-12-31 | 2004-01-27 | $38.26 million | $0.30 | $0.29 | 3.45% |
| 2003-09-30 | 2003-10-23 | $37.99 million | $0.30 | $0.28 | 7.14% |
| 2003-06-30 | 2003-08-12 | $39.43 million | $0.31 | $0.30 | 3.33% |
| 2003-03-31 | 2003-05-01 | $37.74 million | $0.30 | $0.27 | 11.11% |
| 2002-12-31 | 2003-01-28 | $33.3 million | $0.23 | $0.25 | -8% |
| 2002-09-30 | 2002-10-25 | $34.55 million | $0.25 | $0.25 | 0% |
| 2002-06-30 | 2002-08-13 | $35.64 million | $0.26 | $0.25 | 4% |
| 2002-03-31 | 2002-04-23 | $34.29 million | $0.25 | $0.24 | 4.17% |
| 2001-12-31 | 2002-01-29 | $31.14 million | $0.20 | $0.21 | -4.76% |
| 2001-09-30 | 2001-10-18 | $29.84 million | $0.20 | $0.19 | 5.26% |
| 2001-06-30 | 2001-08-14 | $30.71 million | $0.22 | $0.22 | 0% |
| 2001-03-31 | 2001-05-01 | $30.24 million | $0.21 | $0.20 | 5% |
| 2000-12-31 | 2001-01-30 | $26.69 million | $0.16 | $0.16 | 0% |
| 2000-09-30 | 2000-10-24 | $27.72 million | $0.18 | $0.18 | 0% |
| 2000-06-30 | 2000-08-15 | $27.31 million | $0.20 | $0.17 | 17.65% |
| 2000-03-31 | 2000-04-25 | $26.78 million | $0.18 | $0.14 | 28.57% |
| 1999-12-31 | 2000-02-08 | $0.13 | $0.11 | 18.18% | |
| 1999-09-30 | 1999-10-21 | $0.12 | $0.11 | 9.09% | |
| 1999-06-30 | 1999-08-10 | $0.12 | $0.12 | 0% | |
| 1999-03-31 | 1999-04-26 | $0.11 | $0.11 | 0% | |
| 1998-12-31 | 1999-02-02 | $0.09 | $0.08 | 12.5% | |
| 1998-09-30 | 1998-10-22 | $0.09 | $0.07 | 28.57% | |
| 1998-06-30 | 1998-08-11 | $0.13 | $0.11 | 18.18% | |
| 1998-03-31 | 1998-04-28 | $0.10 | $0.09 | 11.11% | |
| 1997-12-31 | 1998-02-03 | $0.08 | $0.08 | 0% | |
| 1997-09-30 | 1997-10-23 | $0.08 | $0.08 | 0% | |
| 1997-06-30 | 1997-08-12 | $0.09 | $0.08 | 12.5% | |
| 1997-03-31 | 1997-04-22 | $0.08 | $0.07 | 14.29% | |
| 1996-12-31 | 1997-01-28 | $0.06 | $0.06 | 0% | |
| 1996-09-30 | 1996-10-24 | $0.06 | $0.06 | 0% | |
| 1996-06-30 | 1996-08-15 | $0.07 | $0.07 | 0% | |
| 1996-03-31 | 1996-04-22 | $0.07 | $0.06 | 16.67% | |
| 1995-12-31 | 1995-12-31 | $0.04 | |||
| 1995-09-30 | 1995-09-30 | $0.05 | |||
| 1995-06-30 | 1995-06-30 | $0.05 | |||
| 1995-03-31 | 1995-03-31 | $0.05 |
Bio-Techne Corporation (TECH) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Bio-Techne Corporation (TECH) Chart:
Bio-Techne Corporation (TECH) News:
Below you will find a list of latest news for Bio-Techne Corporation (TECH) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Bio-Techne Corporation (TECH) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-11-15 | 40 | 0 | CALL | 0 | 0 | 98.06 | TRUE | 0 | 0 |
| 2024-11-15 | 45 | 0 | CALL | 0 | 0 | 68.37 | TRUE | 0 | 0 |
| 2024-11-15 | 50 | 0 | CALL | 0 | 0 | 50.31 | TRUE | 0 | 0 |
| 2024-11-15 | 55 | 0 | CALL | 0 | 0 | 56.7 | TRUE | 0 | 0 |
| 2024-11-15 | 60 | 0 | CALL | 0 | 0 | 49.55 | TRUE | 0 | 0 |
| 2024-11-15 | 65 | 0 | CALL | 0 | 0 | 47.07 | TRUE | 0 | 0 |
| 2024-11-15 | 70 | 0 | CALL | 0 | 0 | 45.37 | TRUE | 0 | 0 |
| 2024-11-15 | 75 | 6.15 | CALL | 10 | 0 | 38.5 | TRUE | 6.15 | 0 |
| 2024-11-15 | 80 | 2.3 | CALL | 0 | 8 | 35.39 | FALSE | 0 | 0 |
| 2024-11-15 | 85 | 1.55 | CALL | 12 | 904 | 34.63 | FALSE | -0.65 | -0.3 |
| 2024-11-15 | 90 | 0 | CALL | 0 | 0 | 43.34 | FALSE | 0 | 0 |
| 2024-11-15 | 95 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 100 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 105 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 110 | 0.15 | CALL | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 115 | 0.25 | CALL | 0 | 4 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 40 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 45 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 50 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 55 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 60 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 65 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 70 | 0 | PUT | 0 | 0 | 44.32 | FALSE | 0 | 0 |
| 2024-11-15 | 75 | 3.12 | PUT | 0 | 19 | 35.13 | FALSE | 0 | 0 |
| 2024-11-15 | 80 | 0 | PUT | 0 | 0 | 30.49 | TRUE | 0 | 0 |
| 2024-11-15 | 85 | 0 | PUT | 0 | 0 | 35.19 | TRUE | 0 | 0 |
| 2024-11-15 | 90 | 0 | PUT | 0 | 0 | 35.01 | TRUE | 0 | 0 |
| 2024-11-15 | 95 | 0 | PUT | 0 | 0 | 41.92 | TRUE | 0 | 0 |
| 2024-11-15 | 100 | 0 | PUT | 0 | 0 | 45.49 | TRUE | 0 | 0 |
| 2024-11-15 | 105 | 0 | PUT | 0 | 0 | 47.16 | TRUE | 0 | 0 |
| 2024-11-15 | 110 | 0 | PUT | 0 | 0 | 56.57 | TRUE | 0 | 0 |
| 2024-11-15 | 115 | 0 | PUT | 0 | 0 | 58.92 | TRUE | 0 | 0 |
| 2025-01-17 | 40 | 0 | CALL | 0 | 0 | 68.75 | TRUE | 0 | 0 |
| 2025-01-17 | 45 | 0 | CALL | 0 | 0 | 55.29 | TRUE | 0 | 0 |
| 2025-01-17 | 50 | 0 | CALL | 0 | 0 | 54.74 | TRUE | 0 | 0 |
| 2025-01-17 | 55 | 0 | CALL | 0 | 0 | 46.87 | TRUE | 0 | 0 |
| 2025-01-17 | 60 | 0 | CALL | 0 | 0 | 41.35 | TRUE | 0 | 0 |
| 2025-01-17 | 65 | 18.9 | CALL | 0 | 1 | 39.07 | TRUE | 0 | 0 |
| 2025-01-17 | 70 | 13.24 | CALL | 0 | 0 | 37.54 | TRUE | 0 | 0 |
| 2025-01-17 | 75 | 7.74 | CALL | 0 | 66 | 35.33 | TRUE | 0 | 0 |
| 2025-01-17 | 80 | 7.5 | CALL | 0 | 23 | 36.48 | FALSE | 0 | 0 |
| 2025-01-17 | 85 | 4 | CALL | 0 | 36 | 33.56 | FALSE | 0 | 0 |
| 2025-01-17 | 90 | 1.78 | CALL | 0 | 5 | 33.16 | FALSE | 0 | 0 |
| 2025-01-17 | 95 | 1.6 | CALL | 0 | 5 | 37.57 | FALSE | 0 | 0 |
| 2025-01-17 | 100 | 0 | CALL | 0 | 0 | 41.16 | FALSE | 0 | 0 |
| 2025-01-17 | 105 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 110 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 115 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 120 | 0.7 | CALL | 0 | 14 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 125 | 0.6 | CALL | 0 | 25 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 40 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 45 | 0.85 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 50 | 1.25 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 55 | 1.65 | PUT | 0 | 15 | 61.18 | FALSE | 0 | 0 |
| 2025-01-17 | 60 | 2.4 | PUT | 0 | 11 | 53.17 | FALSE | 0 | 0 |
| 2025-01-17 | 65 | 1.65 | PUT | 0 | 17 | 42.49 | FALSE | 0 | 0 |
| 2025-01-17 | 70 | 2.6 | PUT | 0 | 13 | 38.16 | FALSE | 0 | 0 |
| 2025-01-17 | 75 | 0 | PUT | 0 | 0 | 36.27 | FALSE | 0 | 0 |
| 2025-01-17 | 80 | 0 | PUT | 0 | 0 | 35.15 | TRUE | 0 | 0 |
| 2025-01-17 | 85 | 0 | PUT | 0 | 0 | 32.72 | TRUE | 0 | 0 |
| 2025-01-17 | 90 | 0 | PUT | 0 | 0 | 31.76 | TRUE | 0 | 0 |
| 2025-01-17 | 95 | 0 | PUT | 0 | 0 | 32.34 | TRUE | 0 | 0 |
| 2025-01-17 | 100 | 0 | PUT | 0 | 0 | 35.29 | TRUE | 0 | 0 |
| 2025-01-17 | 105 | 26.9 | PUT | 0 | 0 | 40.36 | TRUE | 0 | 0 |
| 2025-01-17 | 110 | 0 | PUT | 0 | 0 | 39.71 | TRUE | 0 | 0 |
| 2025-01-17 | 115 | 0 | PUT | 0 | 0 | 47.3 | TRUE | 0 | 0 |
| 2025-01-17 | 120 | 0 | PUT | 0 | 0 | 47.75 | TRUE | 0 | 0 |
| 2025-01-17 | 125 | 0 | PUT | 0 | 0 | 51.47 | TRUE | 0 | 0 |
| 2025-04-17 | 40 | 0 | CALL | 0 | 0 | 49.44 | TRUE | 0 | 0 |
| 2025-04-17 | 45 | 0 | CALL | 0 | 0 | 44.4 | TRUE | 0 | 0 |
| 2025-04-17 | 50 | 0 | CALL | 0 | 0 | 43.67 | TRUE | 0 | 0 |
| 2025-04-17 | 55 | 0 | CALL | 0 | 0 | 42.75 | TRUE | 0 | 0 |
| 2025-04-17 | 60 | 0 | CALL | 0 | 0 | 38.85 | TRUE | 0 | 0 |
| 2025-04-17 | 65 | 0 | CALL | 0 | 0 | 37.7 | TRUE | 0 | 0 |
| 2025-04-17 | 70 | 0 | CALL | 0 | 0 | 35.41 | TRUE | 0 | 0 |
| 2025-04-17 | 75 | 0 | CALL | 0 | 0 | 35.91 | TRUE | 0 | 0 |
| 2025-04-17 | 80 | 0 | CALL | 0 | 0 | 34.4 | FALSE | 0 | 0 |
| 2025-04-17 | 85 | 6.1 | CALL | 0 | 7 | 33.53 | FALSE | 0 | 0 |
| 2025-04-17 | 90 | 3 | CALL | 0 | 10 | 32.69 | FALSE | 0 | 0 |
| 2025-04-17 | 95 | 2.13 | CALL | 0 | 2 | 32.1 | FALSE | 0 | 0 |
| 2025-04-17 | 100 | 2.61 | CALL | 0 | 8 | 31.15 | FALSE | 0 | 0 |
| 2025-04-17 | 105 | 0 | CALL | 0 | 0 | 33.82 | FALSE | 0 | 0 |
| 2025-04-17 | 110 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 40 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 45 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 50 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 55 | 2 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 60 | 2.76 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 65 | 2.75 | PUT | 0 | 1 | 37.84 | FALSE | 0 | 0 |
| 2025-04-17 | 70 | 4.1 | PUT | 0 | 5 | 35.34 | FALSE | 0 | 0 |
| 2025-04-17 | 75 | 0 | PUT | 0 | 0 | 35.12 | FALSE | 0 | 0 |
| 2025-04-17 | 80 | 0 | PUT | 0 | 0 | 33.88 | TRUE | 0 | 0 |
| 2025-04-17 | 85 | 0 | PUT | 0 | 0 | 31.5 | TRUE | 0 | 0 |
| 2025-04-17 | 90 | 0 | PUT | 0 | 0 | 30.04 | TRUE | 0 | 0 |
| 2025-04-17 | 95 | 0 | PUT | 0 | 0 | 29.9 | TRUE | 0 | 0 |
| 2025-04-17 | 100 | 0 | PUT | 0 | 0 | 29.87 | TRUE | 0 | 0 |
| 2025-04-17 | 105 | 0 | PUT | 0 | 0 | 32.18 | TRUE | 0 | 0 |
| 2025-04-17 | 110 | 0 | PUT | 0 | 0 | 34.15 | TRUE | 0 | 0 |
Latest TECH Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 18 | $325.34 |
| Jun 13, 2022 7:59 PM EST | 45 | $325.34 |
| Jun 13, 2022 7:59 PM EST | 4 | $325.06 |
| Jun 13, 2022 7:59 PM EST | 2 | $325.06 |
| Jun 13, 2022 7:59 PM EST | 4 | $325.34 |
Bio-Techne Corporation (TECH) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020004079/0001562180-20-004079-index.htm |
| 2018-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/842023/000021545718005898/0000215457-18-005898-index.htm |
| 2019-01-24 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/842023/000021545719000933/0000215457-19-000933-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/842023/000083423720001545/0000834237-20-001545-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/842023/000083423720009053/0000834237-20-009053-index.htm |
| 2018-08-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419018000352/0000914190-18-000352-index.htm |
| 2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000256/0000914190-19-000256-index.htm |
| 2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000257/0000914190-19-000257-index.htm |
| 2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000258/0000914190-19-000258-index.htm |
| 2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000259/0000914190-19-000259-index.htm |
| 2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000260/0000914190-19-000260-index.htm |
| 2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000261/0000914190-19-000261-index.htm |
| 2019-08-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000308/0000914190-19-000308-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000328/0000914190-19-000328-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000329/0000914190-19-000329-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000330/0000914190-19-000330-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000331/0000914190-19-000331-index.htm |
| 2019-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000370/0000914190-19-000370-index.htm |
| 2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm |
| 2019-11-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm |
| 2019-12-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm |
| 2019-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm |
| 2019-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000476/0000914190-19-000476-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000519/0000914190-19-000519-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000520/0000914190-19-000520-index.htm |
| 2019-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419019000524/0000914190-19-000524-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000018/0000914190-20-000018-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000070/0000914190-20-000070-index.htm |
| 2020-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000109/0000914190-20-000109-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000160/0000914190-20-000160-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000167/0000914190-20-000167-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000186/0000914190-20-000186-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/0000914190-20-000196-index.htm |
| 2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000245/0000914190-20-000245-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000247/0000914190-20-000247-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000249/0000914190-20-000249-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000251/0000914190-20-000251-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000253/0000914190-20-000253-index.htm |
| 2020-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000289/0000914190-20-000289-index.htm |
| 2020-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000290/0000914190-20-000290-index.htm |
| 2020-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000291/0000914190-20-000291-index.htm |
| 2020-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000091419020000292/0000914190-20-000292-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/842023/000093247119004923/0000932471-19-004923-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/842023/000110465920017773/0001104659-20-017773-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/842023/000139834419002785/0001398344-19-002785-index.htm |
| 2018-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/842023/000143774918009213/0001437749-18-009213-index.htm |
| 2018-05-25 | SD | https://www.sec.gov/Archives/edgar/data/842023/000143774918010740/0001437749-18-010740-index.htm | |
| 2018-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774918012358/0001437749-18-012358-index.htm |
| 2018-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774918014310/0001437749-18-014310-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774918014634/0001437749-18-014634-index.htm |
| 2018-08-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/842023/000143774918016190/0001437749-18-016190-index.htm |
| 2018-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774918016625/0001437749-18-016625-index.htm |
| 2018-09-11 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/842023/000143774918016854/0001437749-18-016854-index.htm |
| 2018-09-11 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/842023/000143774918016855/0001437749-18-016855-index.htm |
| 2018-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774918018887/0001437749-18-018887-index.htm |
| 2018-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774918018994/0001437749-18-018994-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/842023/000143774918019736/0001437749-18-019736-index.htm |
| 2018-11-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/842023/000143774918019746/0001437749-18-019746-index.htm |
| 2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774919001827/0001437749-19-001827-index.htm |
| 2019-02-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/842023/000143774919002066/0001437749-19-002066-index.htm |
| 2019-04-15 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/842023/000143774919007189/0001437749-19-007189-index.htm |
| 2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774919008208/0001437749-19-008208-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/842023/000143774919008875/0001437749-19-008875-index.htm |
| 2019-05-29 | SD | https://www.sec.gov/Archives/edgar/data/842023/000143774919010933/0001437749-19-010933-index.htm | |
| 2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774919012693/0001437749-19-012693-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774919015521/0001437749-19-015521-index.htm |
| 2019-08-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/842023/000143774919017565/0001437749-19-017565-index.htm |
| 2019-09-09 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/842023/000143774919018072/0001437749-19-018072-index.htm |
| 2019-09-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/842023/000143774919018073/0001437749-19-018073-index.htm |
| 2019-10-09 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/842023/000143774919019836/0001437749-19-019836-index.htm |
| 2019-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774919020780/0001437749-19-020780-index.htm |
| 2019-11-06 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/842023/000143774919021760/0001437749-19-021760-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/842023/000143774919021764/0001437749-19-021764-index.htm |
| 2020-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774920001618/0001437749-20-001618-index.htm |
| 2020-02-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/842023/000143774920001901/0001437749-20-001901-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774920008902/0001437749-20-008902-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/842023/000143774920010135/0001437749-20-010135-index.htm |
| 2020-05-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774920011291/0001437749-20-011291-index.htm |
| 2020-05-29 | SD | https://www.sec.gov/Archives/edgar/data/842023/000143774920011970/0001437749-20-011970-index.htm | |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774920016374/0001437749-20-016374-index.htm |
| 2020-08-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/842023/000143774920018754/0001437749-20-018754-index.htm |
| 2020-09-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/842023/000143774920019750/0001437749-20-019750-index.htm |
| 2020-09-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/842023/000143774920019751/0001437749-20-019751-index.htm |
| 2020-11-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774920022390/0001437749-20-022390-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/842023/000143774920022618/0001437749-20-022618-index.htm |
| 2018-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018002166/0001562180-18-002166-index.htm |
| 2018-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018002455/0001562180-18-002455-index.htm |
| 2018-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018002938/0001562180-18-002938-index.htm |
| 2018-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018003542/0001562180-18-003542-index.htm |
| 2018-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/0001562180-18-003543-index.htm |
| 2018-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018003544/0001562180-18-003544-index.htm |
| 2018-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018003545/0001562180-18-003545-index.htm |
| 2018-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018003560/0001562180-18-003560-index.htm |
| 2018-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018003561/0001562180-18-003561-index.htm |
| 2018-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018003787/0001562180-18-003787-index.htm |
| 2018-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018003802/0001562180-18-003802-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018004303/0001562180-18-004303-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018004304/0001562180-18-004304-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018004305/0001562180-18-004305-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018004306/0001562180-18-004306-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018004307/0001562180-18-004307-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018004308/0001562180-18-004308-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218018004309/0001562180-18-004309-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218019002477/0001562180-19-002477-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218019002478/0001562180-19-002478-index.htm |
| 2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218019003162/0001562180-19-003162-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218019003396/0001562180-19-003396-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218019003526/0001562180-19-003526-index.htm |
| 2019-07-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218019003803/0001562180-19-003803-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218019003807/0001562180-19-003807-index.htm |
| 2019-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm |
| 2019-07-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020003482/0001562180-20-003482-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020004079/0001562180-20-004079-index.htm |
| 2020-07-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm |
| 2020-08-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020005326/0001562180-20-005326-index.htm |
| 2020-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020005331/0001562180-20-005331-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020006487/0001562180-20-006487-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020006488/0001562180-20-006488-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020006489/0001562180-20-006489-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020006491/0001562180-20-006491-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020006492/0001562180-20-006492-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020006499/0001562180-20-006499-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020006500/0001562180-20-006500-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020006501/0001562180-20-006501-index.htm |
| 2020-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000162440419000009/0001624404-19-000009-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000162440419000010/0001624404-19-000010-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000162440419000011/0001624404-19-000011-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000162440419000012/0001624404-19-000012-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000162440419000013/0001624404-19-000013-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000162440419000014/0001624404-19-000014-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000162440419000015/0001624404-19-000015-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/842023/000162440419000016/0001624404-19-000016-index.htm |
Bio-Techne Corporation (TECH) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bio-Techne Corporation (TECH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 59%Institutional Ownership: 9581%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-03-04 | Norman David Eansor | President-Protein Sciences | Sell | 1,387.00 | 198.68 | 275,569.16 | 0.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000109/0000914190-20-000109-index.htm |
| 2020-05-21 | Norman David Eansor | President-Protein Sciences | Sell | 900.00 | 268.89 | 241,996.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm |
| 2020-05-22 | Norman David Eansor | President-Protein Sciences | Sell | 4,924.00 | 268.41 | 1,321,636.07 | 0.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm |
| 2020-05-28 | Norman David Eansor | President-Protein Sciences | Sell | 3,448.00 | 260.19 | 897,134.09 | 0.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm |
| 2020-05-29 | Norman David Eansor | President-Protein Sciences | Sell | 709.00 | 264.01 | 187,184.44 | 0.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm |
| 2019-06-12 | Norman David Eansor | SVP - Novus Biologicals | Sell | 3,117.00 | 215.00 | 670,155.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003526/0001562180-19-003526-index.htm |
| 2019-09-09 | Charles R. Kummeth | Chief Executive Officer | Buy | 100.00 | 185.00 | 18,500.00 | 100.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000370/0000914190-19-000370-index.htm |
| 2019-07-10 | Charles R. Kummeth | Chief Executive Officer | Sell | 6,566.00 | 212.75 | 1,396,910.59 | 102,579.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm |
| 2019-12-12 | Brenda S. Furlow | SVP - General Counsel | Sell | 426.00 | 214.32 | 91,300.15 | 10,285.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm |
| 2020-05-28 | Brenda S. Furlow | SVP - General Counsel | Buy | 1,600.00 | 94.35 | 150,960.00 | 10,306.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/0000914190-20-000196-index.htm |
| 2020-10-29 | RUPERT VESSEY | Director | Buy | 391.00 | 1,033.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006499/0001562180-20-006499-index.htm | ||
| 2020-11-04 | James Hippel | Chief Financial Officer | Sell | 1,600.00 | 274.53 | 439,254.40 | 10,337.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2020-11-05 | James Hippel | Chief Financial Officer | Sell | 3,249.00 | 287.98 | 935,648.32 | 10,346.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2019-08-07 | Charles R. Kummeth | Chief Executive Officer | Buy | 11,291.00 | 103,467.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000256/0000914190-19-000256-index.htm | ||
| 2020-07-09 | Brenda S. Furlow | SVP - General Counsel | Sell | 2,042.00 | 273.33 | 558,143.33 | 10,403.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm |
| 2020-07-06 | James Hippel | Chief Financial Officer | Sell | 1,934.00 | 273.71 | 529,358.04 | 10,576.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm |
| 2019-12-12 | Brenda S. Furlow | SVP - General Counsel | Buy | 8,000.00 | 94.35 | 754,800.00 | 10,711.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm |
| 2019-07-09 | Charles R. Kummeth | Chief Executive Officer | Buy | 15,037.00 | 67.46 | 1,014,396.02 | 107,213.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm |
| 2019-11-22 | James Hippel | Chief Financial Officer | Sell | 22,051.00 | 215.55 | 4,753,051.15 | 10,907.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm |
| 2019-07-10 | Charles R. Kummeth | Chief Executive Officer | Buy | 16,969.00 | 67.46 | 1,144,728.74 | 109,145.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm |
| 2019-07-08 | Charles R. Kummeth | Chief Executive Officer | Buy | 17,994.00 | 67.46 | 1,213,875.24 | 110,170.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm |
| 2020-05-21 | Norman David Eansor | President-Protein Sciences | Buy | 11,037.00 | 94.35 | 1,041,340.95 | 11,037.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm |
| 2019-08-13 | Charles R. Kummeth | Chief Executive Officer | Buy | 7,410.00 | 67.46 | 499,878.60 | 110,877.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000308/0000914190-19-000308-index.htm |
| 2020-05-21 | ROBERT V BAUMGARTNER | Director | Sell | 1,601.00 | 266.07 | 425,979.03 | 11,320.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm |
| 2020-08-09 | James Hippel | Chief Financial Officer | Buy | 4,438.00 | 11,321.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000290/0000914190-20-000290-index.htm | ||
| 2020-07-07 | James Hippel | Chief Financial Officer | Sell | 414.00 | 270.56 | 112,010.47 | 11,470.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm |
| 2020-07-07 | James Hippel | Chief Financial Officer | Buy | 2,577.00 | 108.49 | 279,578.73 | 11,884.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm |
| 2020-11-04 | James Hippel | Chief Financial Officer | Sell | 2,745.00 | 273.65 | 751,156.62 | 11,937.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2019-11-25 | Roeland Nusse | Director | Sell | 8,347.00 | 219.33 | 1,830,730.82 | 12,374.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm |
| 2020-07-09 | Brenda S. Furlow | SVP - General Counsel | Sell | 505.00 | 272.48 | 137,601.29 | 12,445.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm |
| 2020-07-06 | James Hippel | Chief Financial Officer | Sell | 4,947.00 | 272.34 | 1,347,256.09 | 12,510.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm |
| 2018-10-25 | Alpna Seth | Director | Buy | 514.00 | 1,253.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018004308/0001562180-18-004308-index.htm | ||
| 2018-10-25 | JOSEPH D KEEGAN | Director | Buy | 514.00 | 1,253.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018004305/0001562180-18-004305-index.htm | ||
| 2020-05-22 | Norman David Eansor | President-Protein Sciences | Buy | 8,637.00 | 108.49 | 937,028.13 | 12,600.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm |
| 2018-08-24 | ROBERT V BAUMGARTNER | Director | Buy | 5,000.00 | 61.46 | 307,300.00 | 12,712.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018003787/0001562180-18-003787-index.htm |
| 2020-10-29 | Roeland Nusse | Director | Buy | 391.00 | 12,765.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006492/0001562180-20-006492-index.htm | ||
| 2020-05-21 | ROBERT V BAUMGARTNER | Director | Sell | 1,300.00 | 265.35 | 344,959.81 | 12,921.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm |
| 2020-07-09 | Brenda S. Furlow | SVP - General Counsel | Sell | 440.00 | 270.97 | 119,225.00 | 12,950.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm |
| 2019-12-20 | Charles R. Kummeth | Chief Executive Officer | Sell | 5,767.00 | 222.06 | 1,280,631.55 | 129,989.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000520/0000914190-19-000520-index.htm |
| 2019-12-23 | Charles R. Kummeth | Chief Executive Officer | Sell | 659.00 | 222.08 | 146,350.85 | 129,989.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000524/0000914190-19-000524-index.htm |
| 2019-12-24 | Charles R. Kummeth | Chief Executive Officer | Sell | 471.00 | 222.18 | 104,648.38 | 129,989.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000524/0000914190-19-000524-index.htm |
| 2020-01-02 | Charles R. Kummeth | Chief Executive Officer | Sell | 92.00 | 221.13 | 20,343.50 | 129,989.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm |
| 2020-01-03 | Charles R. Kummeth | Chief Executive Officer | Sell | 1,741.00 | 218.23 | 379,938.43 | 129,989.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm |
| 2020-01-06 | Charles R. Kummeth | Chief Executive Officer | Sell | 10,276.00 | 217.28 | 2,232,769.28 | 129,989.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000018/0000914190-20-000018-index.htm |
| 2020-01-02 | Charles R. Kummeth | Chief Executive Officer | Sell | 775.00 | 220.28 | 170,717.00 | 130,081.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm |
| 2018-08-23 | JOHN L HIGGINS | Director | Buy | 10,000.00 | 61.08 | 610,800.00 | 13,012.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419018000352/0000914190-18-000352-index.htm |
| 2019-12-24 | Charles R. Kummeth | Chief Executive Officer | Buy | 471.00 | 67.46 | 31,773.66 | 130,460.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000524/0000914190-19-000524-index.htm |
| 2019-12-23 | Charles R. Kummeth | Chief Executive Officer | Buy | 659.00 | 67.46 | 44,456.14 | 130,648.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000524/0000914190-19-000524-index.htm |
| 2020-01-02 | Charles R. Kummeth | Chief Executive Officer | Sell | 9,245.00 | 219.32 | 2,027,613.40 | 130,856.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm |
| 2020-01-03 | Charles R. Kummeth | Chief Executive Officer | Sell | 6,258.00 | 217.37 | 1,360,301.46 | 131,730.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm |
| 2018-08-08 | Charles A Dinarello | Director | Buy | 5,000.00 | 63.03 | 315,150.00 | 13,212.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018003560/0001562180-18-003560-index.htm |
| 2020-07-09 | Brenda S. Furlow | SVP - General Counsel | Buy | 9,079.00 | 108.49 | 984,980.71 | 13,390.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm |
| 2019-12-20 | Charles R. Kummeth | Chief Executive Officer | Buy | 5,767.00 | 67.46 | 389,041.82 | 135,756.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000520/0000914190-19-000520-index.htm |
| 2019-11-29 | Charles R. Kummeth | Chief Executive Officer | Sell | 100.00 | 222.62 | 22,262.36 | 135,756.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm |
| 2019-12-10 | Charles R. Kummeth | Chief Executive Officer | Sell | 703.00 | 222.01 | 156,073.03 | 135,756.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000476/0000914190-19-000476-index.htm |
| 2019-08-19 | Charles R. Kummeth | Chief Executive Officer | Buy | 24,979.00 | 135,856.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000329/0000914190-19-000329-index.htm | ||
| 2019-11-27 | Charles R. Kummeth | Chief Executive Officer | Sell | 11,772.00 | 222.12 | 2,614,814.30 | 135,856.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm |
| 2020-11-05 | James Hippel | Chief Financial Officer | Sell | 121.00 | 287.15 | 34,745.07 | 13,595.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2019-12-10 | Charles R. Kummeth | Chief Executive Officer | Buy | 703.00 | 67.46 | 47,424.38 | 136,459.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000476/0000914190-19-000476-index.htm |
| 2020-11-05 | James Hippel | Chief Financial Officer | Sell | 1,630.00 | 285.12 | 464,739.90 | 13,716.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2020-01-03 | Charles R. Kummeth | Chief Executive Officer | Buy | 7,999.00 | 67.46 | 539,612.54 | 137,988.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm |
| 2020-01-02 | Charles R. Kummeth | Chief Executive Officer | Sell | 3,282.00 | 218.42 | 716,854.44 | 140,101.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm |
| 2020-01-06 | Charles R. Kummeth | Chief Executive Officer | Buy | 10,276.00 | 67.46 | 693,218.96 | 140,265.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000018/0000914190-20-000018-index.htm |
| 2020-05-21 | ROBERT V BAUMGARTNER | Director | Buy | 5,000.00 | 70.35 | 351,750.00 | 14,221.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm |
| 2020-01-02 | Charles R. Kummeth | Chief Executive Officer | Sell | 6,449.00 | 217.40 | 1,402,012.60 | 143,383.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm |
| 2020-11-04 | James Hippel | Chief Financial Officer | Sell | 1,555.00 | 272.71 | 424,063.89 | 14,682.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2019-07-01 | RUPERT VESSEY | Director | Buy | 147.00 | 147.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003807/0001562180-19-003807-index.htm | ||
| 2019-11-27 | Charles R. Kummeth | Chief Executive Officer | Buy | 11,772.00 | 67.46 | 794,139.12 | 147,628.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000434/0000914190-19-000434-index.htm |
| 2020-01-02 | Charles R. Kummeth | Chief Executive Officer | Buy | 19,843.00 | 67.46 | 1,338,608.78 | 149,832.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/0000914190-20-000014-index.htm |
| 2020-05-26 | Charles R. Kummeth | Chief Executive Officer | Buy | 21,159.00 | 86.25 | 1,824,963.75 | 151,148.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000186/0000914190-20-000186-index.htm |
| 2020-08-05 | Charles R. Kummeth | Chief Executive Officer | Buy | 8,586.00 | 152,483.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000253/0000914190-20-000253-index.htm | ||
| 2020-11-05 | James Hippel | Chief Financial Officer | Sell | 325.00 | 283.64 | 92,183.00 | 15,346.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2020-11-05 | James Hippel | Chief Financial Officer | Sell | 1,674.00 | 282.52 | 472,938.98 | 15,671.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2019-11-25 | Roeland Nusse | Director | Buy | 10,000.00 | 60.46 | 604,600.00 | 15,721.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm |
| 2020-11-04 | James Hippel | Chief Financial Officer | Buy | 7,100.00 | 108.49 | 770,279.00 | 16,237.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2019-05-01 | Kim Kelderman | President, Diagnostics & Genom | Buy | 1,667.00 | 202.13 | 336,950.71 | 1,667.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019002478/0001562180-19-002478-index.htm |
| 2020-11-05 | James Hippel | Chief Financial Officer | Sell | 203.00 | 281.27 | 57,098.64 | 17,345.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2020-08-09 | Charles R. Kummeth | Chief Executive Officer | Buy | 21,291.00 | 173,774.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000289/0000914190-20-000289-index.htm | ||
| 2020-07-06 | James Hippel | Chief Financial Officer | Sell | 3,781.00 | 271.53 | 1,026,667.41 | 17,457.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm |
| 2019-10-24 | Alpna Seth | Director | Buy | 495.00 | 1,748.00 | https://www.sec.gov/Archives/edgar/data/842023/000162440419000011/0001624404-19-000011-index.htm | ||
| 2019-10-24 | JOSEPH D KEEGAN | Director | Buy | 495.00 | 1,748.00 | https://www.sec.gov/Archives/edgar/data/842023/000162440419000016/0001624404-19-000016-index.htm | ||
| 2020-11-05 | James Hippel | Chief Financial Officer | Sell | 398.00 | 280.28 | 111,550.25 | 17,548.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2020-11-05 | James Hippel | Chief Financial Officer | Buy | 8,809.00 | 108.49 | 955,688.41 | 17,946.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2019-11-21 | James Hippel | Chief Financial Officer | Buy | 11,349.00 | 94.35 | 1,070,778.15 | 20,656.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm |
| 2019-11-25 | Roeland Nusse | Director | Buy | 5,000.00 | 61.46 | 307,300.00 | 20,721.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000428/0000914190-19-000428-index.htm |
| 2020-07-06 | James Hippel | Chief Financial Officer | Sell | 9,571.00 | 270.45 | 2,588,507.58 | 21,238.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm |
| 2020-10-29 | Alpna Seth | Director | Buy | 391.00 | 2,139.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006487/0001562180-20-006487-index.htm | ||
| 2020-10-29 | JOSEPH D KEEGAN | Director | Buy | 391.00 | 2,139.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006491/0001562180-20-006491-index.htm | ||
| 2020-08-09 | Norman David Eansor | President-Protein Sciences | Buy | 2,174.00 | 2,174.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000291/0000914190-20-000291-index.htm | ||
| 2019-05-24 | Brenda S. Furlow | SVP - General Counsel | Sell | 5,400.00 | 200.00 | 1,080,000.00 | 2,189.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003162/0001562180-19-003162-index.htm |
| 2018-05-04 | Norman David Eansor | SVP - Novus Biologicals | Sell | 1,136.00 | 145.19 | 164,931.75 | 2,266.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018002455/0001562180-18-002455-index.htm |
| 2019-08-19 | Norman David Eansor | SVP - Novus Biologicals | Buy | 2,287.00 | 2,287.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000331/0000914190-19-000331-index.htm | ||
| 2020-05-01 | Kim Kelderman | Pres. Diagnostics & Genom | Buy | 1,666.00 | 2,489.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000167/0000914190-20-000167-index.htm | ||
| 2018-08-07 | Brenda S. Furlow | SVP - General Counsel | Buy | 959.00 | 2,627.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/0001562180-18-003543-index.htm | ||
| 2019-12-12 | Brenda S. Furlow | SVP - General Counsel | Sell | 200.00 | 216.75 | 43,350.00 | 2,711.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm |
| 2020-05-29 | Norman David Eansor | President-Protein Sciences | Sell | 3,400.00 | 261.74 | 889,926.54 | 2,809.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm |
| 2019-12-12 | Brenda S. Furlow | SVP - General Counsel | Sell | 4,147.00 | 216.01 | 895,783.93 | 2,911.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm |
| 2018-08-23 | JOHN L HIGGINS | Director | Sell | 10,000.00 | 187.92 | 1,879,173.00 | 3,012.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419018000352/0000914190-18-000352-index.htm |
| 2020-07-06 | James Hippel | Chief Financial Officer | Buy | 21,502.00 | 108.49 | 2,332,751.98 | 30,809.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm |
| 2019-11-22 | James Hippel | Chief Financial Officer | Buy | 23,651.00 | 94.35 | 2,231,471.85 | 32,958.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm |
| 2020-05-28 | Norman David Eansor | President-Protein Sciences | Buy | 3,448.00 | 108.49 | 374,073.52 | 3,448.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm |
| 2018-08-07 | Norman David Eansor | SVP - Novus Biologicals | Buy | 1,199.00 | 3,465.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018003544/0001562180-18-003544-index.htm | ||
| 2018-10-25 | JOHN L HIGGINS | Director | Buy | 514.00 | 3,526.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018004304/0001562180-18-004304-index.htm | ||
| 2019-06-04 | JOHN L HIGGINS | Director | Sell | 5,000.00 | 203.67 | 1,018,345.50 | 3,526.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003396/0001562180-19-003396-index.htm |
| 2019-05-01 | James Hippel | Chief Financial Officer | Buy | 35,000.00 | 86.25 | 3,018,750.00 | 39,382.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019002477/0001562180-19-002477-index.htm |
| 2019-08-19 | Brenda S. Furlow | SVP - General Counsel | Buy | 1,759.00 | 3,948.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000328/0000914190-19-000328-index.htm | ||
| 2020-05-22 | Norman David Eansor | President-Protein Sciences | Buy | 3,963.00 | 94.35 | 373,909.05 | 3,963.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm |
| 2019-10-24 | JOHN L HIGGINS | Director | Buy | 495.00 | 4,021.00 | https://www.sec.gov/Archives/edgar/data/842023/000162440419000010/0001624404-19-000010-index.htm | ||
| 2020-02-12 | JOHN L HIGGINS | Director | Sell | 5,000.00 | 205.23 | 1,026,132.50 | 4,021.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000070/0000914190-20-000070-index.htm |
| 2018-10-25 | RANDOLPH C STEER | Director | Buy | 514.00 | 4,226.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018004309/0001562180-18-004309-index.htm | ||
| 2020-05-28 | Brenda S. Furlow | SVP - General Counsel | Sell | 3,800.00 | 260.38 | 989,453.50 | 4,311.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/0000914190-20-000196-index.htm |
| 2020-07-09 | Brenda S. Furlow | SVP - General Counsel | Sell | 74.00 | 278.84 | 20,634.16 | 4,311.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm |
| 2019-05-01 | James Hippel | Chief Financial Officer | Sell | 35,000.00 | 203.08 | 7,107,681.00 | 4,382.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019002477/0001562180-19-002477-index.htm |
| 2020-07-09 | Brenda S. Furlow | SVP - General Counsel | Sell | 2,746.00 | 278.06 | 763,555.51 | 4,385.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm |
| 2020-10-29 | JOHN L HIGGINS | Director | Buy | 391.00 | 4,412.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006489/0001562180-20-006489-index.htm | ||
| 2019-10-24 | RANDOLPH C STEER | Director | Buy | 495.00 | 4,721.00 | https://www.sec.gov/Archives/edgar/data/842023/000162440419000013/0001624404-19-000013-index.htm | ||
| 2018-10-25 | HAROLD J WIENS | Director | Buy | 514.00 | 4,726.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018004307/0001562180-18-004307-index.htm | ||
| 2020-10-29 | Julie L Bushman | Director | Buy | 391.00 | 480.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006488/0001562180-20-006488-index.htm | ||
| 2020-05-29 | HAROLD J WIENS | Director | Sell | 3,985.00 | 260.00 | 1,036,100.00 | 4,843.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020004079/0001562180-20-004079-index.htm |
| 2020-05-22 | Norman David Eansor | President-Protein Sciences | Sell | 7,676.00 | 267.63 | 2,054,289.50 | 4,924.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm |
| 2020-10-29 | RANDOLPH C STEER | Director | Buy | 391.00 | 5,112.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006500/0001562180-20-006500-index.htm | ||
| 2019-10-24 | HAROLD J WIENS | Director | Buy | 495.00 | 5,221.00 | https://www.sec.gov/Archives/edgar/data/842023/000162440419000015/0001624404-19-000015-index.htm | ||
| 2019-12-04 | HAROLD J WIENS | Director | Sell | 80.00 | 219.31 | 17,545.11 | 5,221.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm |
| 2020-04-30 | HAROLD J WIENS | Director | Sell | 4,000.00 | 225.00 | 900,000.00 | 5,221.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000160/0000914190-20-000160-index.htm |
| 2020-05-06 | HAROLD J WIENS | Director | Sell | 4,260.00 | 250.00 | 1,065,000.00 | 5,221.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020003482/0001562180-20-003482-index.htm |
| 2018-10-25 | Roeland Nusse | Director | Buy | 514.00 | 5,226.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018004306/0001562180-18-004306-index.htm | ||
| 2019-12-04 | HAROLD J WIENS | Director | Sell | 921.00 | 218.75 | 201,472.89 | 5,301.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm |
| 2018-08-07 | James Hippel | Chief Financial Officer | Buy | 2,398.00 | 5,477.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018003542/0001562180-18-003542-index.htm | ||
| 2019-10-24 | Roeland Nusse | Director | Buy | 495.00 | 5,721.00 | https://www.sec.gov/Archives/edgar/data/842023/000162440419000012/0001624404-19-000012-index.htm | ||
| 2020-08-09 | Brenda S. Furlow | SVP - General Counsel | Buy | 1,724.00 | 6,035.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000292/0000914190-20-000292-index.htm | ||
| 2020-05-29 | Norman David Eansor | President-Protein Sciences | Sell | 1,700.00 | 260.83 | 443,409.64 | 6,209.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm |
| 2019-12-04 | HAROLD J WIENS | Director | Sell | 514.00 | 217.29 | 111,684.59 | 6,222.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm |
| 2019-10-24 | RUPERT VESSEY | Director | Buy | 495.00 | 642.00 | https://www.sec.gov/Archives/edgar/data/842023/000162440419000014/0001624404-19-000014-index.htm | ||
| 2019-12-04 | HAROLD J WIENS | Director | Sell | 485.00 | 216.47 | 104,990.23 | 6,736.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm |
| 2019-12-12 | Brenda S. Furlow | SVP - General Counsel | Sell | 3,227.00 | 215.17 | 694,337.78 | 7,058.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/0000914190-19-000488-index.htm |
| 2020-05-29 | Norman David Eansor | President-Protein Sciences | Sell | 2,100.00 | 262.68 | 551,619.39 | 709.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm |
| 2020-07-09 | Brenda S. Furlow | SVP - General Counsel | Sell | 1,954.00 | 277.28 | 541,812.15 | 7,131.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm |
| 2019-12-04 | HAROLD J WIENS | Director | Buy | 2,000.00 | 87.83 | 175,660.00 | 7,221.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000460/0000914190-19-000460-index.htm |
| 2019-05-24 | Brenda S. Furlow | SVP - General Counsel | Buy | 5,400.00 | 7,589.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003162/0001562180-19-003162-index.htm | ||
| 2018-06-07 | Charles R. Kummeth | Chief Executive Officer | Sell | 8,000.00 | 160.00 | 1,280,000.00 | 76,472.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018002938/0001562180-18-002938-index.htm |
| 2018-08-24 | ROBERT V BAUMGARTNER | Director | Sell | 5,000.00 | 188.47 | 942,333.50 | 7,712.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018003787/0001562180-18-003787-index.htm |
| 2020-05-29 | Norman David Eansor | President-Protein Sciences | Buy | 7,909.00 | 108.49 | 858,047.41 | 7,909.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000195/0000914190-20-000195-index.htm |
| 2020-05-28 | Brenda S. Furlow | SVP - General Counsel | Sell | 2,195.00 | 259.72 | 570,079.25 | 8,111.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/0000914190-20-000196-index.htm |
| 2018-08-08 | Charles A Dinarello | Director | Sell | 5,000.00 | 176.94 | 884,675.00 | 8,212.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018003560/0001562180-18-003560-index.htm |
| 2018-10-25 | ROBERT V BAUMGARTNER | Director | Buy | 514.00 | 8,226.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018004303/0001562180-18-004303-index.htm | ||
| 2019-06-04 | JOHN L HIGGINS | Director | Buy | 5,000.00 | 63.03 | 315,150.00 | 8,526.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003396/0001562180-19-003396-index.htm |
| 2020-05-28 | Brenda S. Furlow | SVP - General Counsel | Buy | 5,995.00 | 108.49 | 650,397.55 | 8,706.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/0000914190-20-000196-index.htm |
| 2019-08-07 | ROBERT V BAUMGARTNER | Director | Buy | 500.00 | 191.06 | 95,530.00 | 8,726.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000261/0000914190-19-000261-index.htm |
| 2020-05-29 | HAROLD J WIENS | Director | Buy | 3,985.00 | 101.19 | 403,242.15 | 8,828.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020004079/0001562180-20-004079-index.htm |
| 2020-08-03 | Julie L Bushman | Director | Buy | 89.00 | 89.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020005331/0001562180-20-005331-index.htm | ||
| 2020-05-21 | Norman David Eansor | President-Protein Sciences | Sell | 10,137.00 | 267.37 | 2,710,319.55 | 900.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000183/0000914190-20-000183-index.htm |
| 2020-02-12 | JOHN L HIGGINS | Director | Buy | 5,000.00 | 61.46 | 307,300.00 | 9,021.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000070/0000914190-20-000070-index.htm |
| 2018-08-07 | Charles R. Kummeth | Chief Executive Officer | Buy | 13,816.00 | 90,288.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018003545/0001562180-18-003545-index.htm | ||
| 2020-07-09 | Brenda S. Furlow | SVP - General Counsel | Sell | 400.00 | 276.03 | 110,410.00 | 9,085.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm |
| 2020-11-04 | James Hippel | Chief Financial Officer | Sell | 1,200.00 | 275.79 | 330,951.72 | 9,137.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2020-11-05 | James Hippel | Chief Financial Officer | Sell | 100.00 | 293.66 | 29,366.00 | 9,137.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2019-07-08 | Charles R. Kummeth | Chief Executive Officer | Sell | 17,994.00 | 212.75 | 3,828,183.91 | 92,176.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm |
| 2019-07-09 | Charles R. Kummeth | Chief Executive Officer | Sell | 15,037.00 | 212.43 | 3,194,339.98 | 92,176.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003915/0001562180-19-003915-index.htm |
| 2019-07-10 | Charles R. Kummeth | Chief Executive Officer | Sell | 494.00 | 214.07 | 105,749.69 | 92,176.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm |
| 2020-04-30 | HAROLD J WIENS | Director | Buy | 4,000.00 | 91.78 | 367,120.00 | 9,221.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000160/0000914190-20-000160-index.htm |
| 2019-10-24 | ROBERT V BAUMGARTNER | Director | Buy | 495.00 | 9,221.00 | https://www.sec.gov/Archives/edgar/data/842023/000162440419000009/0001624404-19-000009-index.htm | ||
| 2020-05-21 | ROBERT V BAUMGARTNER | Director | Sell | 125.00 | 267.94 | 33,492.58 | 9,221.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm |
| 2020-11-05 | James Hippel | Chief Financial Officer | Sell | 750.00 | 291.06 | 218,297.03 | 9,237.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |
| 2019-07-10 | Charles R. Kummeth | Chief Executive Officer | Sell | 9,909.00 | 213.32 | 2,113,768.06 | 92,670.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218019003930/0001562180-19-003930-index.htm |
| 2019-08-19 | James Hippel | Chief Financial Officer | Buy | 4,925.00 | 9,307.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000330/0000914190-19-000330-index.htm | ||
| 2019-11-21 | James Hippel | Chief Financial Officer | Sell | 11,349.00 | 215.36 | 2,444,131.99 | 9,307.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm |
| 2019-11-22 | James Hippel | Chief Financial Officer | Sell | 1,600.00 | 216.16 | 345,850.24 | 9,307.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419019000420/0000914190-19-000420-index.htm |
| 2020-07-06 | James Hippel | Chief Financial Officer | Sell | 1,269.00 | 274.52 | 348,362.96 | 9,307.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm |
| 2020-07-07 | James Hippel | Chief Financial Officer | Sell | 500.00 | 272.26 | 136,130.00 | 9,307.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm |
| 2020-05-21 | ROBERT V BAUMGARTNER | Director | Sell | 1,974.00 | 267.32 | 527,685.34 | 9,346.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000182/0000914190-20-000182-index.htm |
| 2018-08-08 | Charles R. Kummeth | Chief Executive Officer | Buy | 11,279.00 | 93,514.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218018003545/0001562180-18-003545-index.htm | ||
| 2020-05-06 | HAROLD J WIENS | Director | Buy | 4,260.00 | 87.34 | 372,068.40 | 9,481.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020003482/0001562180-20-003482-index.htm |
| 2020-07-09 | Brenda S. Furlow | SVP - General Counsel | Sell | 918.00 | 274.80 | 252,270.81 | 9,485.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/0001562180-20-005109-index.htm |
| 2020-10-29 | ROBERT V BAUMGARTNER | Director | Buy | 391.00 | 9,612.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006501/0001562180-20-006501-index.htm | ||
| 2020-07-07 | James Hippel | Chief Financial Officer | Sell | 1,663.00 | 271.40 | 451,341.36 | 9,807.00 | https://www.sec.gov/Archives/edgar/data/842023/000091419020000237/0000914190-20-000237-index.htm |
| 2020-11-05 | James Hippel | Chief Financial Officer | Sell | 359.00 | 289.39 | 103,889.50 | 9,987.00 | https://www.sec.gov/Archives/edgar/data/842023/000156218020006582/0001562180-20-006582-index.htm |